Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”

The authors have drawn to the attention of the editor in chief of the journal errors in the following paper: Chen et al. Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection. Biochemistry Insights 2015;8(S1):25–29. doi:10.4137/BCI.S30753. The original funding statement in the article was incorrect. The correct funding statement is as follows:

FUNDING: This work is supported by a scientific research project from the Education Department of Sichuan Province (13ZB0229). The authors confirm that the funder had no influence over the study design, content of the article, or selection of this journal.

The editor in chief thanks the authors for bringing this error to the attention of the journal.